These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2254323)

  • 1. Bifunctional thrombin inhibitors based on the sequence of hirudin45-65.
    DiMaio J; Gibbs B; Munn D; Lefebvre J; Ni F; Konishi Y
    J Biol Chem; 1990 Dec; 265(35):21698-703. PubMed ID: 2254323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
    DiMaio J; Ni F; Gibbs B; Konishi Y
    FEBS Lett; 1991 Apr; 282(1):47-52. PubMed ID: 2026264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a linker for trivalent thrombin inhibitors: interaction of the main chain of the linker with thrombin.
    Szewczuk Z; Gibbs BF; Yue SY; Purisima E; Zdanov A; Cygler M; Konishi Y
    Biochemistry; 1993 Apr; 32(13):3396-404. PubMed ID: 8461303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N alpha-acetyl-hirudin45-65.
    Krstenansky JL; Mao SJ
    FEBS Lett; 1987 Jan; 211(1):10-6. PubMed ID: 3803584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interactions of a bifunctional inhibitor with alpha-thrombin by molecular modelling and peptide synthesis.
    Yue SY; DiMaio J; Szewczuk Z; Purisima EO; Ni F; Konishi Y
    Protein Eng; 1992 Jan; 5(1):77-85. PubMed ID: 1631048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
    Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
    J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
    Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T; Rothe M; Dodt J
    Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal binding domain of hirullin P18. Antithrombin activity and comparison to hirudin peptides.
    Krstenansky JL; Owen TJ; Yates MT; Mao SJ
    FEBS Lett; 1990 Sep; 269(2):425-9. PubMed ID: 2401369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant activity of synthetic hirudin peptides.
    Maraganore JM; Chao B; Joseph ML; Jablonski J; Ramachandran KL
    J Biol Chem; 1989 May; 264(15):8692-8. PubMed ID: 2722794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally restricted thrombin inhibitors resistant to proteolytic digestion.
    Szewczuk Z; Gibbs BF; Yue SY; Purisima EO; Konishi Y
    Biochemistry; 1992 Sep; 31(38):9132-40. PubMed ID: 1390700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.
    Maraganore JM; Bourdon P; Jablonski J; Ramachandran KL; Fenton JW
    Biochemistry; 1990 Jul; 29(30):7095-101. PubMed ID: 2223763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
    Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a homologous series of ketomethylene arginyl pseudodipeptides and application to low molecular weight hirudin-like thrombin inhibitors.
    DiMaio J; Gibbs B; Lefebvre J; Konishi Y; Munn D; Yue SY; Hornberger W
    J Med Chem; 1992 Sep; 35(18):3331-41. PubMed ID: 1527782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fibrinogen anion-binding exosite of thrombin is necessary for induction of rises in intracellular calcium and prostacyclin production in endothelial cells.
    Ngaiza JR; Manley G; Grulich-Henn J; Krstenansky JL; Jaffe EA
    J Cell Physiol; 1992 Apr; 151(1):190-6. PubMed ID: 1560043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors.
    Tsuda Y; Cygler M; Gibbs BF; Pedyczak A; Féthière J; Yue SY; Konishi Y
    Biochemistry; 1994 Dec; 33(48):14443-51. PubMed ID: 7981204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirulog peptides with scissile bond replacements resistant to thrombin cleavage.
    Kline T; Hammond C; Bourdon P; Maraganore JM
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1049-55. PubMed ID: 2059196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct binding sites of Ala48-hirudin1-47 and Ala48-hirudin48-65 on alpha-thrombin.
    Dodt J; Köhler S; Schmitz T; Wilhelm B
    J Biol Chem; 1990 Jan; 265(2):713-8. PubMed ID: 2295615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.